Voluntary announcement ICF004 completes enrolment and dosing of first healthy volunteer in phase i clinical trial
Filed with HKEX · Stock code 2652 · · 3 pages · English
CF PharmTech, Inc. 長風藥業股份有限公司 (A joint stock company incorporated in the People's Republic of China with limited liability) (Stock Code: 2652) VOLUNTARY ANNOUNCEMENT ## ICF004 COMPLETES ENROLMENT AND DOSING OF FIRST HEALTHY ## VOLUNTEER IN PHASE I CLINICAL TRIAL This announcement is made by CF PharmTech, Inc. (the “Company”, together with its subsidiaries, the “Group”) on a voluntary basis to info
Earlier from CF PharmTech
Later from CF PharmTech
- 2026 Interim Report
- Voluntary announcement voluntary extension of lock-up period for shares held by core management by six months
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
Follow CF PharmTech into a list and get an email when it puts out news.
Follow CF PharmTech